COMPANY PROFILE

Aro Homes

Explore full profile

Builds better homes for people and the planet

San Francisco, United StatesFounded 2021Real Estate

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Aro Homes

Aro Homes is a forward-thinking company dedicated to revolutionizing the housing construction industry by engineering and building highly sustainable, intelligent, and livable homes. The company serves environmentally conscious homebuyers who seek modern, energy-efficient living spaces. Operating in the residential real estate market, Aro Homes leverages cutting-edge architectural and design expertise to create homes that use less water and energy, thereby reducing environmental impact.

The business model focuses on delivering high-quality, sustainable homes quickly and efficiently. Revenue is generated through the sale of these homes to individual buyers who prioritize sustainability and modern living. Aro Homes is backed by notable investors, including Eric Schmidt's Innovation Endeavors, which has a history of investing in disruptive and visionary companies.

Aro Homes differentiates itself by its unrelenting focus on customer needs and its commitment to innovation. The company encourages taking smart risks and learning by doing, fostering an environment of continuous improvement and curiosity. This approach ensures that Aro Homes remains at the forefront of sustainable housing solutions.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: San Francisco, United States
Employees: 69
Open positions: 8
Dealroom signal: 81.6/100
Industry: Real Estate
Sub-industry: Construction
Sector: Real Estate, Hard Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Nov 2022	$21M	$84M	Stanford University · Western Technology Investment	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Aro Homes website traffic

Latest recorded traffic for Aro Homes is 11K monthly website visits, down 8.3% over the last three months. Aro Homes's team grew 11.3% over the past year.

Latest monthly visits11K 3-month web change-8.3% 1-year team growth+11.3%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

MEPF EngineerMountain View, CA · Other · Sep 2, 2026 Buyside Strategist / Business Development RepresentativeMountain View, CA · Business Development · Jul 31, 2026 RecruiterMountain View, CA · Human Resources · Jul 6, 2026 Structural EngineerMountain View, CA · Design · Jun 30, 2026 Health, Safety, Environmental & Compliance ManagerSacramento, CA · Other · Jun 19, 2026 Procurement Specialist - Field & Subcontractor OperationsMountain View, CA · Logistics · Jun 12, 2026

6 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HEHemonaplóMobile software company that provides a solution for patients and through the platform	—	Closed	—	$150K	—
VIVicinivaxDeveloping therapeutic cancer vaccines	Groningen, Netherlands	Operational
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
SISideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers	Paris, France	Closed
STStellateDevelops innovative microbiome-derived small molecules to treat neurodegenerative diseases	Paris, France	Closed
EBEVORA BiosciencesExosome-based regenerative therapies for gastrointestinal diseases.	Strasbourg, France	Operational
ISIndicate SolutionsDeveloping a cheap, reliable, rapid, and easy-to-use device to detect DNA mutations in the blood of cancer patients at POC, allowing patients tailored treatment decisions immediately	San Sebastián, Spain	Operational
NENEURALTIDEDedicated to the development of a medical device for the treatment of ischemic strokes	Paris, France	Operational